EJCTS Click here to go to Edwards website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Eur J Cardiothorac Surg 2008;34:685-686. doi:10.1016/j.ejcts.2008.05.022
Copyright © 2008, European Association for Cardio-thoracic Surgery. Published by Elsevier. All rights reserved.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Ravindranath Tiruvoipati
Giles J. Peek
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chalwin, R. P.
Right arrow Articles by Peek, G. J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Chalwin, R. P.
Right arrow Articles by Peek, G. J.
Related Collections
Right arrow Extracorporeal circulation

Case reports

Fatal thrombosis with activated factor VII in a paediatric patient on extracorporeal membrane oxygenation

Richard P. Chalwin, Ravindranath Tiruvoipati*, Giles J. Peek

Department of ECMO, Glenfield Hospital, Leicester, LE3 9QP, UK

Received 30 October 2007; received in revised form 14 April 2008; accepted 19 May 2008.

* Corresponding author. Address: Department of Intensive Care, Frankston Hospital, Frankston, Victoria 3199, Australia. Tel.: +61 431279347; fax: +61 397847398. (Email: travindranath{at}hotmail.com).

Bleeding remains a potential complication for patients requiring extracorporeal life support systems. Recombinant activated factor VII (rFVIIa) is one of the drugs used in controlling bleeding. Its use is generally found to be safe. We report a paediatric patient who developed fatal thrombosis with the use of rFVIIa whilst on extracorporeal membrane oxygenation and discuss the possible factors that lead to fatal thrombosis.

Key Words: Extracorporeal membrane oxygenation • Thrombosis • Bleeding




This article has been cited by other articles:


Home page
 ICVTSHome page
S. Rubin, A. N. Ali, O. N. Pages, and B. Baehrel
How to replace an extracorporeal life support without interruption of the cardiopulmonary assistance
Interactive CardioVascular and Thoracic Surgery, August 1, 2009; 9(2): 311 - 313.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2008 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.